(Q1074056)

triamcinolone (English)

17 November 2016

chemical formula

C₂₁H₂₇FO₆

1 reference

triamcinolone (English)

17 November 2016

canonical SMILES

CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O

1 reference

triamcinolone (English)

17 November 2016

isomeric SMILES

C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)CO)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O

1 reference

triamcinolone (English)

17 November 2016

defined daily dose

0.22 milligram

https://www.whocc.no/atc_ddd_index/?code=R01AD11

nasal administration

1 reference

reference URL

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

1 reference

14 February 2018

World Health Organisation international non-proprietary name

triamcinolone (English)

1 reference

triamcinolone (English)

medical condition treated

3 October 2016

1 reference

systemic lupus erythematosus

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

osteoarthritis susceptibility 1

13 December 2016

1 reference

2 October 2018

keloid

1 reference

2 October 2018

cystoid macular edema

1 reference

2 October 2018

macular retinal edema

1 reference

significant drug interaction

2 October 2018

hydrochlorothiazide

Achor-Smith syndrom

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxifloxacin

Achor-Smith syndrom

1 reference

established

A reference set of clinically relevant adverse drug-drug interactions

aspirin

gastrointestinal haemorrhage

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aspirin

peptic ulcer disease

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ritonavir

Decreased circulating cortisol level

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ritonavir

Cushing's syndrome

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rac-warfarin

retroperitoneal hemorrhage

1 reference

A reference set of clinically relevant adverse drug-drug interactions

acenocoumarol

retroperitoneal hemorrhage

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxifloxacin

tendon rupture

1 reference

established

A reference set of clinically relevant adverse drug-drug interactions

rocuronium

muscle weakness

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rocuronium

muscular disease

1 reference

A reference set of clinically relevant adverse drug-drug interactions

atracurium

muscle weakness

1 reference

A reference set of clinically relevant adverse drug-drug interactions

atracurium

muscular disease

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cisatracurium

muscle weakness

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cisatracurium

muscular disease

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydrochlorothiazide

heart arrhythmia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

physically interacts with

Nuclear receptor subfamily 3 group C member 1

subject has role

agonist

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

2870

17 August 2016

Glucocorticoid receptor

subject has role

agonist

1 reference

Open _targets Platform

https://platform.open_targets.org/drug/CHEMBL1451

14 August 2023

reference URL

pregnancy category

Australian pregnancy category A

1 reference

imported from Wikimedia project

English Wikipedia

US pregnancy category C

1 reference

imported from Wikimedia project

English Wikipedia

subject has role

5-lipoxygenase inhibitor

1 reference

5 March 2018

selective glucocorticoid receptor agonist

1 reference

5 March 2018

anti-inflammatory agent

1 reference

InChI=1S/C21H27FO6/c1-18-6-5-12(24)7-11(18)3-4-13-14-8-15(25)21(28,17(27)10-23)19(14,2)9-16(26)20(13,18)22/h5-7,13-16,23,25-26,28H,3-4,8-10H2,1-2H3/t13-,14-,15+,16-,18-,19-,20-,21-/m0/s1

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

0 references

Triamcinolone

0 references

Identifiers

InChI

1 reference

triamcinolone (English)

17 November 2016

2 references

triamcinolone (English)

17 November 2016

ChEBI release 2020-09-01

CAS Registry Number

124-94-7

2 references

triamcinolone (English)

17 November 2016

https://commonchemistry.cas.org/detail?cas_rn=124-94-7

10 April 2021

1 reference

Triamcinolone (English)

17 November 2016

2 references

triamcinolone (English)

17 November 2016

Reaxys registry number

2341955

1 reference

triamcinolone (English)

3 October 2016

ChEBI ID

9667

mapping relation type

2 references

TRIAMCINOLONE (English)

17 November 2016

International Chemical Identifier

InChI

InChI=1S/C21H27FO6/c1-18-6-5-12(24)7-11(18)3-4-13-14-8-15(25)21(28,17(27)10-23)19(14,2)9-16(26)20(13,18)22/h5-7,13-16,23,25-26,28H,3-4,8-10H2,1-2H3/t13-,14-,15+,16-,18-,19-,20-,21-/m0/s1

1 reference

TRIAMCINOLONE (English)

17 November 2016

2 references

inferred from InChIKey

MSBNK-Athens_Univ-AU240057

1 reference

MassBank accession ID

0 references

MSBNK-Athens_Univ-AU240058

0 references

MSBNK-Athens_Univ-AU240059

0 references

MSBNK-Athens_Univ-AU240060

0 references

SPLASH

splash10-00di-2931000000-ee37afbf8c285181a340

0 references

HSDB ID

3194

1 reference

Hazardous Substances Data Bank

28 October 2019

TRIAMCINOLONE (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

1 reference

triamcinolone (English)

ECHA Substance Infocard ID

17 November 2016

100.004.290

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.004.290

27 December 2018

Triamcinolone (English)

quotation

CAS no.: 124-94-7 (English)

1 reference

Triamcinolone (English)

17 November 2015

1 reference

Triamcinolone (English)

17 November 2015

1 reference

Triamcinolone (English)

17 November 2015

1 reference

Triamcinolone (English)

17 November 2015

1 reference

Triamcinolone (English)

17 November 2015

1 reference

Triamcinolone (English)

17 November 2015

1 reference

Triamcinolone (English)

17 November 2015

1 reference

Guide to Pharmacology Ligand ID

Triamcinolone (English)

publication date

17 November 2015

2870

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

2870

triamcinolone (English)

17 November 2016

Triamcinolone

0 references

MeSH concept ID

M0021894

0 references

MeSH tree code

D04.210.500.745.432.915

0 references

0 references

1 reference

triamcinolone (English)

17 November 2016

DrugBank ID

DB00620

1 reference

Human Metabolome Database ID

HMDB0014758

2 references

based on heuristic

inferred from InChIKey

2 references

triamcinolone (English)

17 November 2016

MedlinePlus drug identifier

a601122

oral administration

0 references

a682791

nasal administration

0 references

a601124

0 references

1 reference

triamcinolone (English)

17 November 2016

0 references

1 reference

1 reference

Gran Enciclopèdia Catalana ID

triamcinolone (English)

3 October 2016

0 references

1 reference

28 October 2013

triamcinolona

0 references

Gran Enciclopèdia Catalana ID (former scheme)

0 references

1 reference

9 July 2020

0 references

Microsoft Academic ID

0 references

1 reference

triamcinolone (English)

17 November 2016

WikiProjectMed ID

Triamcinolone

0 references

WordNet 3.1 Synset ID

15103335-n

1 reference